Clinical trial
Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis
NCT00137371 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00137371 |
|---|---|
| Title | Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis |
| Official title | Efficacy and Safety of 2 Low-Dose Regimens of Conjugated Estrogen Cream Administered Vaginally in Postmenopausal Women With Atrophic Vaginitis |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrophic Vaginitis, Atrophy, Vaginitis |
| Intervention type | Drug |
| Interventions | PVC (daily for 21 days, 7 days off), PVC (twice weekly) |
| Enrollment | 480 |
| Start date | Aug 1, 2005 |
| Completion | Sep 1, 2007 |
| First posted | Aug 29, 2005 |
| Last update posted | Dec 10, 2007 |
| Countries | Canada, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: